Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...
Chemotherapy Medications in Sub-Saharan Africa: Availability, Pricing, Affordability, and Predictors of Quality Breast cancer is the most common cancer and the second leading cause of death among ...
Season 2 of Netflix’s One Piece docks on Tuesday, March 10, as fans eagerly anticipate the next chapter in the adventures of Monkey D. Luffy and his Straw Hat pirate crew. With boundless enthusiasm ...
The Irish Marching Society celebrated 50 years of St. Patrick's Day traditions in downtown Rockford. The anniversary parade featured marching groups, music and local organizations to honor a ...
For Part 2 of our Line Life Podcast series on mental health in the line trade, we are featuring an interview with Jennifer Lavin, the founder of Union Care Solutions, which supports mental health and ...
BILLERICA, Mass.--(BUSINESS WIRE)--Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), today announced a partnership with Life Line Screening (LLS), a national organization focused on ...
Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), today announced a partnership with Life Line Screening (LLS), a national organization focused on identifying asymptomatic risks for ...
NEW YORK – Quanterix brand Lucent Diagnostics announced on Monday that it has signed a partnership agreement with Life Line Screening to offer Lucent's noninvasive blood-based disease testing in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results